HISTOLAB PRODUCTS ApS: Financial statements 2012
CVR: 28292090
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
HISTOLAB PRODUCTS ApS (CVR 28292090) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -8,310 and a net result of DKK -8,307. Equity in the 2012 report amounted to DKK 63,329. The solvency ratio was 86.3%.
- Gross Profit
- DKK -8,310
- Profit/Loss
- DKK -8,307
- Equity
- DKK 63,329
- Total Assets
- DKK 73,377
Official annual report
Keep an eye on HISTOLAB PRODUCTS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of April 27, 2012, Tom Mikael Haglund has joined the board of directors of HISTOLAB PRODUCTS ApS.
As of April 27, 2012, Johan Brage Wulff has joined the board of directors of HISTOLAB PRODUCTS ApS.
As of April 27, 2012, Terhi Saija Tuulevi Niva has left the board of directors of HISTOLAB PRODUCTS ApS.
About HISTOLAB PRODUCTS ApS
HISTOLAB PRODUCTS ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2004. The company is registered under the industry Agenturhandel med specialiseret varesortiment, bortset fra køretøjer. The company was previously named ALGOL PHARMA ApS. The management consists of Caj Patrik Joakim Eurenius. The board consists of Caj Patrik Joakim Eurenius (chair) and Frida Birgitta Ekstrand. The company is owned by Histolab Products AB. The company has 1 employee (2018). In 2025, the company reported revenue of DKK 14,888,720 and a net result of DKK 107,970 compared with DKK 59,499 the year before. Equity in the 2025 report amounted to DKK 3,130,036.